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Abstract
Background: Transmissible spongiform encephalopathy diseases are untreatable, uniformly fatal degenerative
syndromes of the central nervous system that can be transmitted both within as well as between species. The
bovine spongiform encephalopathy (BSE) epidemic and the emergence of a new human variant of Creutzfeldt-
Jakob disease (vCJD), have profoundly influenced beef production processes as well as blood donation and
surgical procedures. Simple, robust and cost effective diagnostic screening and surveillance tools are needed for
both the preclinical and clinical stages of TSE disease in order to minimize both the economic costs and zoonotic
risk of BSE and to further reduce the risk of secondary vCJD.
Objective: Urine is well suited as the matrix for an ante-mortem test for TSE diseases because it would permit
non-invasive and repeated sampling. In this study urine samples collected from BSE infected and age matched
control cattle were screened for the presence of individual proteins that exhibited disease specific changes in
abundance in response to BSE infection that might form the basis of such an ante-mortem test.
Results: Two-dimensional differential gel electrophoresis (2D-DIGE) was used to identify proteins exhibiting
differential abundance in two sets of cattle. The known set consisted of BSE infected steers and age matched
controls throughout the course of the disease. The blinded unknown set was composed of BSE infected and
control samples of both genders, a wide range of ages and two different breeds. Multivariate analyses of individual
protein abundance data generated classifiers comprised of the proteins best able to discriminate between the
samples based on disease state, breed, age and gender.
Conclusion: Despite the presence of confounding factors, the disease specific changes in abundance exhibited by
a panel of urine proteins permitted the creation of classifiers able to discriminate between control and infected
cattle with a high degree of accuracy.
Introduction
Transmissible spongiform encephalopathy (TSE) dis-
eases are untreatable, uniformly fatal degenerative syn-
dromes of the central nervous system that can be
transmitted both within as well as between species.
Bovine spongiform encephalopathy (BSE) of cattle,
chronic wasting disease (CWD) of cervids, scrapie of
sheep and a new variant of Creutzfeldt-Jakob disease
(vCJD) of humans, thought to be acquired through diet-
ary exposure to BSE infect beef as well as iatrogenically,
are among the most notable TSE diseases [1,2].
In response to the association of dietary exposure to
BSE infected beef and the 1996 emergence of vCJD a
variety of risk reduction measures were put in place in
the U.K. Specified risk material (SRM), consisting of tis-
sues known to harbour high levels of infectivity such as
the brain and spinal cord were removed from the food
chain and between 1996-2005 all animals of ≥30 months
of age were also excluded. The introduction of rapid
tests for BSE in 2005 allowed cattle ≥30 months of age
to enter the food chain provided they tested negative for
BSE. Subsequently, in 2008 the countries of the EU
raised the BSE testing age to 48 months [3]. These mea-
sures are presumed able to prevent dietary exposure to
contaminated tissue.
* Correspondence: David.Knox@phac-aspc.gc.ca
1Prion Diseases Program, Public Health Agency of Canada, Winnipeg, R3E
3P6, Canada
Full list of author information is available at the end of the article
Plews et al. Proteome Science 2011, 9:6
http://www.proteomesci.com/content/9/1/6
© 2011 Plews et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.A hallmark of TSE diseases is an accumulation of mis-
folded isoforms of a host-encoded protein, PrP, or prion
protein. The BSE rapid tests rely upon the detection of
the disease associated host-encoded prion protein, PrP
d,
in brain tissue post-mortem and are consequently unsui-
table for assessing the health of breeding stock. Such
tests would also be unsuitable for performing CJD sur-
veillance of prospective blood donors or people under-
going surgical procedures. The risk of secondary
transmission of vCJD has been demonstrated by four
cases of vCJD observed in persons that received transfu-
sions of packed red blood cells from asymptomatic
donors who subsequently died from vCJD [1]. It has
also been recently recognized that heterozygotes might
be similarly susceptible to BSE infection as those homo-
zygous methionine at the polymorphic codon of the
prion gene. This would heighten the risk of secondary
vCJD transmission because heterozygotes represent a
larger proportion of the population exposed to BSE
tainted beef and these individuals remain asymptomatic
and potentially infectious for extended periods of time
[4,5]. Thus, there is continued demand for an ante-mor-
tem TSE test based on a matrix or body fluid that
would permit repeated sampling.
Diagnostic screening and surveillance tools need to be
simple, robust and cost effective. Ideally, such a test
would be comprised of one protein. However, in reality
finding a panel of markers is more likely as well as suffi-
cient. The use of the disease related isoform, PrP
d,a sa
pre-clinical or general marker for surveillance has been
limited, due to the fact that it is present in extremely
small amounts in accessible tissues and bodily fluids.
Specific detection of these small amounts of the PrP
d
conformer are further exacerbated by the presence of
large excesses of endogenous PrP. Efforts to surmount
these problems have relied on the partial protease resis-
tance of PrP
d coupled with signal amplification by the
protein misfolding cyclic amplification assay (PMCA)
[6-8]. Despite early optimism the demonstration that
infectivity is associated with protease sensitive forms of
PrP
d and that PMCA is able to produce PrP
d de novo
means that such techniques are currently unable to
form the basis of an ante-mortem test [9,10]. To cir-
cumvent these problems an alternative, but as yet
unproven strategy has been to identify differentially
abundant host proteins characteristic of TSE infection
to act as surrogate markers of disease [11-13].
Previously, we used 2D-DIGE to perform an unbiased
screen of the urinary proteome of a small cohort of
Fleckvieh-Simmental cows. The results demonstrated
that the relative abundance of a particular isoform of
the glycoprotein clusterin was able to accurately discri-
minate between BSE infected and age matched control
cattle as early as 8 months post infection [13,14]. The
animals of this cohort were all females of the same
breed, inoculated at 4 months of age, and raised in the
same location. The uniformity of this data set was well
suited for the identification of disease specific changes
in the abundance of particular proteins. In contrast,
more stringent criteria must be applied to biomarker
identification as biomarkers are required to exhibit a
reliable response in a heterogeneous population. To
start to address these issues this study describes the ana-
lysis of both a known set and an associated blinded
unknown set that contained BSE infected cattle and
control cattle of different breeds, genders and ages. All
three traits are demonstrated to significantly affect the
urinary proteome. Nonetheless, despite these confound-
ing factors disease specific changes in the individual
abundance of a panel of urinary proteins were able to
discriminate between control and infected cattle with a
high degree of accuracy.
Materials and methods
Urine
Frozen urine samples (20 mL) were received from the
Veterinary Laboratory Agency (VLA, Weybridge, UK)
and stored at -80°C. The known set consisted of 8 neu-
tered males; 4 infected with a 100 g oral dose of BSE at
4-5 months of age and 4 age matched controls. The
breed of the steers was either Friesian or crossbred Frie-
sian-Holstein. Urine samples were collected longitudin-
ally at 5 to 6 month intervals for the first 41 months of
the disease. The blinded unknown set consisted of 19
samples representing 19 individual animals of indetermi-
nate disease status. Animal use for scientific purposes
was reviewed by the VLA Ethics Committee. The VLA
is bound by the Animals (scientific procedures) Act
1986 which is administered by the Home Office. All
samples were processed as described previously [13].
Urine samples were thawed overnight at 4°C. Insoluble
p a r t i c l e sw e r er e m o v e db yap r e - s p i n ,4 ° Ca t4 1 5gf o r
5 minutes. The soluble fraction was concentrated with a
5 K MWCO Centricon Plus-70 centrifugal filter unit
(Millipore) in a swinging bucket rotor at 4°C and 3400 g
for approximately 20 minutes or until volumes reached
less than 4 mL. The urine was further concentrated with
an Amicon 4 ml 5 K MWCO centrifugal filter unit (Milli-
pore) at 4°C and 7000 g until volumes reached 200 μl.
The concentrated urine samples were purified using a
2D Clean Up Kit (GE Healthcare) according to the man-
ufacturer’s recommendations. The resulting protein pel-
lets were resuspended in 100 μLo fD I G El a b e l l i n g
Buffer (0.03 M Tris, 8 M Urea, 2 M Thiourea, 2%
Chaps, pH 8.5). Samples were adjusted to pH8.5 with
the addition of 1-5 μl of 0.05 M NaOH. The concentra-
tion of each sample was determined using a 2D Quant
Kit (GE Healthcare) according to the manufacturer’s
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combining 100 μg of each sample.
2D Gel Electrophoresis
CyDye™ (GE Healthcare) minimal labelling was per-
formed as per the manufacturer’s recommendations
(400 pmol: 50 μg) with the Cy2 label reserved for the
pooled standard. The control and infected samples were
labelled in a randomized manner with either Cy3 or
Cy5. An equal volume of 2 × Rehydration Buffer
( 0 . 0 3MT r i s ,8MU r e a ,2MT h i o u r e a ,2 %C h a p s ,p H
8.5, 4 mg/ml Dithiothreitol (DTT), 1% IPG buffer pH
4-7) was added to a mixture comprised of 30 μg each of
the labelled Pooled, Control and Infected samples. After
a 10 minute incubation on ice approximately 400 μlo f
1 × Rehydration Buffer (0.03 M Tris, 8 M Urea, 2 M
Thiourea, 2% Chaps, pH 8.5, 2 mg/ml DTT, 0.5% IPG
buffer pH 4-7) and 5 μl of 1% Bromophenol blue (10
mM TrisCl pH 8.5) were added to bring the volume up
to a total of 450 μl. The labelled samples were loaded
onto a reswelling tray and overlaid with a 24 cm Immo-
biline DryStrip pH 4-7 (GE Healthcare) and DryStrip
Cover Fluid for rehydration overnight at room tempera-
ture. The strip was transferred to a Manifold filled with
108 mL of DryStrip Cover Fluid and placed on an Ettan
IPGphor3 focusing apparatus that was programmed as
follows: Step 30 V 8 hrs, Step 500 V 1 hr, Step 1000 V
1 hr, Grad 10000 V 3 hrs and Step 10000 V 3 hrs.
A final focusing program: Grad 10000 V 0:20 hr and
Step 10000 V until the volt hours reached a total of
55000 was added, as required.
Completed isoelectric focusing (IEF) strips were stored
at -80°C until the second dimension was started. IEF
strips were prepared for second dimension gels by incu-
bating in two different Equilibration Buffer solutions
(50 mM Tris-Cl pH8.8, 6 M Urea, 30% Glycerol, 2%
SDS, 0.2% Bromophenol Blue, supplemented with
either 65 mM DTT - 1st incubation or 135 mM
Iodoacetamide - 2
nd incubation) for 15 minutes each
with gentle rocking. The equilibrated IEF strips were
placed on 15-20% gradient gels between low fluorescent
glass plates (NextGen Sciences). After sealing in place with
a 1% agarose solution, the gels were placed in the Ettan
DALT6 unit (GE Healthcare) and run at 2 W overnight
and then at 100 W until a total of 3100 Vhr was reached.
Gel image acquisition
Gels were scanned with a Typhoon 9410 variable mode
imager. The known set consisted of 4 infected and 4
control biological replicates at each of the 7 time points.
An exception was infected steer #31 that was culled
prior to 41 months post infection (mpi, Table 1). In
total 28 gels, each comprised of the internal standard
and one or two biological samples were run to produce
55 gel images representing 55 biological samples with
matching images of the internal standard. The blinded
unknown set (Table 2) consisted of 20 samples.
Unknown sample #2 was not analyzed as a suitable gel
image was not obtained. The remaining 19 individual
animals of indeterminate disease status were run on ten
gels that contained the same Cy-2-labelled internal stan-
dard as used for the known set above.
Analysis
The acquired gel images were analyzed using the DeCy-
der™ Differential In-gel Analysis (DIA) and Biological
Variation Analysis (BVA) software modules (version
7.0). Manual landmarking of spot features across all
internal standard images was performed in order to
improve the accuracy of the gel-to-gel matching process.
This resulted in the detection, quantification, and
matching on average 1143 master spot features/gel
across the 38 gels (Figure 1). Classifiers were generated
by the algorithms of the DeCyder™ Extended Data
Analysis Software (EDA) module using the default set-
tings for cross validation. Cross validation involves
Table 1 Samples of the Known Set
MPI Age of animal at terminal collection
Animal ID Gender Breed 6 11 17 23 29 35 41
ctl 3 male Friesian/Holstein √ √√√√√√ 4 years
ctl 8 male Friesian/Holstein √ √√√√√√ 5 years, 1 month
ctl 11 male Friesian √ √√√√√√ 4 years, 1 month
ctl 1822 male Friesian/Holstein √ √√√√√√ 4 years, 10 months
inf 5 male Friesian √ √√√√√√ 3 years, 11 months
inf 9 male Friesian √ √√√√√√ 3 years, 11 months
inf 22 male Friesian √ √√√√√√ 4 years, 2 months
inf 31 male Friesian/Holstein √ √√√√√X 3 years, 5 months
The known set consisted of eight neutered males. Four were orally infected with 100 g of BSE infected brain homogenate. Urine samples were collected at
5-6 month intervals post infection from both the infected and age matched control steers. The breed of the steers is asymmetrically divided between the two
groups. The infected group consists of three Friesians and one crossbred Friesian-Holstein. Conversely the control group consists of the crossbred Friesian-
Holsteins and one Friesian.
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forming the analysis on one subset and validating the
analysis on the other subset. To reduce variability, mul-
tiple rounds of cross validation are performed using dif-
ferent partitions and the results are averaged over the
rounds. Two parameters indicating the quality of the
proteins comprised in the classifiers are calculated by
the DeCyder™ software; appearance (A), the number of
classifiers that have selected this protein, and rank (R),
the mean value of the different classifiers ranking of the
proteins. The master spot features used to generate the
classifiers and PCA plots as well as their rank and
appearance values are provided in Additional file 1,
Table S1.
Results and Discussion
BSE biomarkers
Multivariate analyses of the BVA protein expression
data derived from the known set were performed using
the EDA software module. The gel images of the known
set were grouped according to disease state and months
post infection (mpi). Grouping the 55 gel images of the
known set according to disease state and mpi generated
14 groups each representing either the four infected or
four control animals at particular time points. The data
were filtered so that only the 103 spot features present
in ≥80% of the gels and exhibiting statistically significant
(ANOVA p ≤ 0.01) changes in abundance were consid-
ered in the following analyses. The 103 spot features
were searched and evaluated by the forward selection
(FS) and regularized discriminant analysis (RDA) algo-
rithms to identify the subset of spot features best able
to discriminate between control and infected samples.
Nine selected spot features were used to create an RDA
generated classifier that classified the control and
infected samples of the known set with 90.7 ± 7.1%
accuracy. A PCA based on the classifiers as features was
carried out, illustrating a demarcation between the con-
trol and infected animals (Figure 2). The correct classifi-
cation of the known set samples obtained from animals
e a r l yi nt h ed i s e a s ec o u r s e( 6m p i )d e m o n s t r a t e dt h a t
changes in the abundance of some proteins occurs
rapidly after BSE infection via the oral route (Figure 2).
This confirmed the results observed previously with
Fleckvieh-Simmental cows [13].
The high degree of the calculated accuracy indicated
that the disease status of the animals was a major influ-
ence affecting the differential abundance of individual
p r o t e i n si nu r i n e .H o w e v e r ,at r u em e a s u r eo ft h ep e r -
formance of the classifier requires that it be applied to
an independent data set not involved in the determina-
tion of the classifier parameters. When applied to the 19
samples in the independent unknown data set the classi-
fier generated by the known set was able to discriminate
Table 2 Samples of the Unknown Set
Unknown Sample # Gender Breed Age Disease Classification
1 male Friesian/Holstein 10 years, 4 months negative negative
3 female Friesian 4 years, 9 months negative negative
4 female Friesian/Holstein 10 years, 7 months positive positive
5 female Friesian 4 years, 8 months positive positive
6 female Friesian 4 years, 9 months negative negative
7 male Friesian/Holstein 10 years, 7 months negative positive
8 female Friesian 8 years, 1 month positive positive
9 female Friesian/Holstein 5 years, 0 months positive negative
10 female Friesian 4 years, 9 months negative negative
11 female Friesian 5 years, 5 months negative positive
12 female Friesian 10 years, 4 months positive positive
13 female Friesian 9 years, 4 months positive positive
14 male Friesian/Holstein 10 years, 4 months negative negative
15 female Friesian 10 years, 4 months positive positive
16 male Friesian/Holstein 10 years, 4 months negative positive
17 female Friesian 5 years, 5 months negative positive
18 female Friesian/Holstein 5 years, 0 months positive positive
19 female Friesian 4 years, 8 months positive positive
20 female Friesian 5 years, 5 months negative negative
The gender, breed and age of the animal from which the samples were obtained are given in columns two, three, and four respectively. In column five the true
disease state of the animals is given and in column 6 it is indicated how the samples were classified by the known set generated classifier. A suitable gel image
of sample #2 was not obtained.
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Page 4 of 11between control and infected samples with 74% accu-
racy. The classification resulted in 4 false positives and 1
false negative. Thus in the context of detecting infected
cattle the classifier performed well in comparison to the
detection of 14-3-3 proteins in cerebral spinal fluid as a
marker for sporadic CJD patients [15,16]. Principle com-
ponent analysis was carried out on the 19 samples of the
unknown data set using the nine features that com-
prised the classifier to visually illustrate classification of
the spot maps (Figure 3).
Confounding Factors
An assumption built into the assessment of the true
accuracy of the classifier was that both the known and
unknown sets were representative of the same ‘cow
population’. Inspection of the details of the cattle from
the known and unknown sets revealed that in fact the
cattle populating the two data sets were dramatically dif-
ferent. One factor well known to influence urine com-
position is gender [17]. Gender differences surely played
ar o l ea st h ek n o w ns e tw a sc o m p o s e de n t i r e l yo f
neutered males while 15 of the 19 animals of the
blinded unknown set were females (Table 2). Age of the
animals has also been shown to influence transcriptional
profiles and the urine proteome [13,18]. All the animals
of the known set were under 5.5 years of age. In con-
t r a s t ,9o ft h e1 9a n i m a l so ft h eu n k n o w ns e tw e r e8
years of age or older (Table 2). Tabulating the known
information about the source of the urine samples
clearly illustrates that the samples of the known set used
to create the classifier were not representative of the
‘cow population’ of the blinded unknown set (Table 3).
Another variable came to light once all the parameters
of the unknown set were known. When choosing the
known set we had purposely selected a longitudinal ser-
ies of samples in order to determine how early in the
disease course we would be able to identify BSE positive
animals. In contrast, the infected urine samples of the
unknown set were all obtained from naturally infected
animals exhibiting clinical signs indicative of BSE and
subsequently definitively diagnosed as BSE positive by
post mortem analysis.
649 647
780
839
964
1017
92 92
172
420
pH4ĺ7
Figure 1 Representative Cy2-labelled internal standard proteome gel image illustrating proteins resolved in the pH4-7range. The gel
image as loaded into the DIA module prior to spot detection. The blue arrows indicate the nine spot features of the known set that comprised
the classifier used to classify the unknown set.
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The difference in disease stage between the two data sets
can be lessened by considering just the last sample col-
lected from each animal of the known set. At this time
point (35 or 41 mpi) the infected animals of the known set
were all showing clinical symptoms of BSE infection mak-
ing them comparable to the infected samples of the
unknown set. All control animals in both the known and
unknown sets were non BSE exposed and in good physical
shape. A merged set containing the last sample collected
from each of the 8 animals of the known set with the 19
individual samples of the unknown set was formed to
determine the contributions of breed, age and gender to
the protein profile of urine (Additional file 2, Table S2).
Breed
Prior analyses of the known set, where age and gender
were not factors, clearly demonstrated that the different
breeds differentially influenced the urine protein profile
(Additional file 3, Figure S1). A new classifier was cre-
ated based on different breeds. When applied to the
merged set it too demonstrated that breed influenced
the abundance of a panel of proteins to a significant
degree (82.5 ± 12.6%). The resulting PCA based on
these features shows the misclassified Friesians as part
of the cluster of FriesianXHolsteins and the one misclas-
sified FriesanXHolstein was closer to the Friesian cluster
(Figure 4). Five samples of the merged set were misclas-
sified. Interestingly, 4 of the misclassified samples were
Friesian steers of the known set that were correctly clas-
sified with respect to breed when the known set was
analyzed in isolation. This indicated that factors in addi-
tion to disease state and breed were having a marked
influence on the protein composition of urine. The
other misclassified sample was unknown set #4. The
crossbreed Friesian-Holstein infected cow that produced
this sample was the oldest animal in the merged set sug-
gesting that age might also play a role.
Age
The age of the animals producing the samples of the
merged set ranged from 3.4 to 10.6 years of age. The
absence of animals between the ages of 5.4 and 8.1
years of age provided a clear demarcation between the 9
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Figure 2 Principle component analysis of the 55 biological samples of the known set using the nine spots features best able to
discriminate between control and infected samples. Five samples are misclassified using this classifier producing one false positive and four
false negatives. The arrows indicate the misclassified samples and the table provides their identity. The only similarity between the misclassified
samples is that they are relatively early in the disease course. (PC1 = 48.8, PC2 = 20.6).
Plews et al. Proteome Science 2011, 9:6
http://www.proteomesci.com/content/9/1/6
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be ‘young’ (Table 3). When grouped as old and young
with respect to the animals that produced them a classi-
fier created to discriminate age correctly classified the
samples with 95.0 ± 11.2% accuracy (Figure 5). PCA,
using the 5 features of this classifier visually illustrates
the misclassified Friesian cow of age 9.3 in midst of the
younger cows.
Gender
When grouped according to the gender of the animal
that produced them the samples of the merged set are
broken into a group of 15 samples produced by females
and a group of 12 samples produced by neutered males.
Discriminant analysis of gender resulted in a classifier
that could correctly classify gender with 100% accuracy.
PCA based on the four features of this classifier resulted
in two completely separated clusters illustrating the suc-
cessful classification based on this classifier (Figure 6).
The PCA plot was also a clear example that despite
being focused on gender the influence of other factors
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Disease Classification
Figure 3 Principle component analysis of the unknown set using the classifier generated by the known set. The number adjacent to
each spot identifies the unknown set sample it represents. The colour of the centre of each circle identifies its true disease state (blue = BSE
negative, red = BSE positive). The positions of the misclassified samples (7, 9, 11, 16, 17) are indicated by arrows. The perimeter colour indicates
how these samples were classified by the known set classifier as opposed to their true identity indicated by the colour of the interior of the
circles. When applied to the unknown set the known set classifier generates four false positives and one false negative. (PC1 = 40.5, PC2 = 22.5).
Table 3 Compare and Contrast the Samples of the
Known and Unknown Sets
Unknown Set
Age of Animals When Samples
Obtained
BSE
Status
male female
F HxF F HxF
≥ 8 years old Positive 0 0 4 1
Negative 0 4 0 0
≤ 6 years old Positive 0 0 2 2
Negative 0 0 6 0
Known Set
≥ 8 years old Positive 0 0 0 0
Negative 0 0 0 0
≤ 6 years old Positive 3 1 0 0
Negative 1 3 0 0
The animals producing the samples of the known set were all relatively young
steers. In contrast 15 of the samples of the test set were produced by females
and five of these were much older in age than the samples of the known set.
The unknown set also included four steers, but none of these were of the
same age range as the steers of the known set. Note that the known set
animals are located in the bottom left quadrant of the table that is
unpopulated by animals of the unknown set.
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Figure 4 Principle component analysis of samples grouped according to breed. To lessen the effects of differences due to disease stage
the 27 samples of the merged set consist of the eight terminal samples of the known set and all the samples of the unknown set. When
grouped according to breed 122 proteins were present on 80% of the gels and showed significant differential abundance (ANOVA p ≤ 0.01).
The 122 proteins were analyzed using the FS and RDA algorithms to identify those proteins best able to discriminate between the two breeds
of cattle. RDA was used to generate a classifier out of the 12 selected proteins that was able to correctly classify the samples with 82.5 ± 12.6%
accuracy. The misclassified samples are identified by arrows and the sample number to which they correspond. (K = known set, U = unknown
set, PC1 = 70.2, PC2 = 12.3).
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Figure 5 Principle component analysis of the samples grouped according to age. The 27 samples of the merged set were divided into
two groups. One containing the 9 animals over 8 years of age and the other containing the 18 animals under 6 years of age. The 44 proteins
present in 100% of the gels and exhibiting significant differential abundance (ANOVA p ≤ 0.01) were analyzed using the partial least squares
search and RDA algorithms to identify those proteins best able to differentiate between the samples based on the age of the animal that
produced them. RDA was used to generate a classifier out of the 5 selected proteins that was able to correctly classify the samples with 95.0 ±
11.2% accuracy. The misclassified sample, unknown set sample 13, is indicated by an arrow. (PC1 = 56.2, PC2 = 27.0).
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together in the lower right hand quadrant of the PCA
plot are all BSE negative, Friesian-Holstein crossbreeds
and over 10 years of age.
Disease Status
Ultimately, it was of interest to determine how accurate
a classifier based on disease induced changes in the
abundance of particular proteins could be created in
samples where breed, age and gender significantly
affected the protein profile of the urine samples. When
the samples of the merged set were grouped based upon
their disease state a group of 13 samples produced by
BSE positive animals and another group of 15 samples
produced by BSE negative animals were generated.
When grouped in this fashion a new clinical stage classi-
fier was able to sort the control and infected samples of
the merged set with 96.7 ± 7.5% accuracy. Applying
PCA to this set of 10 features in the classifier, resulted
in only one infected animal as part of the control cluster
(Figure 7).
Conclusions
Our earlier observation, that BSE induced changes in
the protein profile of urine occur shortly after oral infec-
tion, was confirmed. This result suggests that the diag-
nosis of acquired TSE diseases may be possible at a
time prior to the accumulation of irreversible damage
when future interventions may be most effective. Discre-
pancies between the known and unknown sets pre-
cluded a true assessment of the performance of the
classifier produced by the known set. Nonetheless, by
creating a merged set combining the last sample
obtained from each animal of the known set with the
samples of the unknown set we were able to gauge the
effects of breed, age, and gender as well as disease state.
The results demonstrated that, at the clinical stage of
the disease, factors such as breed, age and gender signif-
icantly affected the protein profile of urine. Despite
these confounding factors disease specific changes in the
abundance of a panel of proteins, able to discriminate
between control and clinical stage infected cattle, can be
observed in this complex data set. A true measurement
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Figure 6 Principle component analysis of the samples grouped according to gender. The 27 samples of the merged set were divided into
two groups. One group contained the 12 steers and the other contained the 15 cows. The 185 proteins present in 100% of the gels and
exhibiting significant differential abundance (ANOVA p ≤ 0.01) were analyzed using the PLSS and RDA algorithms to identify those proteins best
able to differentiate between the samples based on the gender of the animal that produced them. RDA was used to generate a classifier out of
the 4 selected proteins that correctly classified all the samples with respect to gender. (PC1 = 66.8, PC2 = 20.7).
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Page 9 of 11of the performance of the classifier generated by the
merged set will require the future testing of naive sam-
ple sets. Once validated the proteins of the classifier
would be individually identified.
Additional material
Additional file 1: Table S1 Master Spot Features Used as Classifiers.
The spot features used to generate each of the classifiers discussed and
the corresponding figures are listed. The appearance (A) and rank (R) of
each protein are parameters indicating the quality of the protein relative
to the other proteins included in each classifier.
Additional file 2: Table S2 The Merged Set. The last urine sample
obtained from each of the 8 animals of the known set was added to the
19 samples of the unknown set to create a set referred to as the merged
set. The gender, breed, age, and disease status of these 27 animals are
given in columns 2-5 respectively.
Additional file 3: Figure S1 The Effect of Breed on the Urine Protein
Profiles of the Known Set. The 55 samples of the known set were
divided into two groups based on breed. The 126 proteins present in
80% of the gels and exhibiting significant differential abundance (ANOVA
p ≤ 0.01) were analyzed using the FS and K-Nearest Neighbours
algorithms to identify those proteins best able to differentiate between
the samples based upon the breed of animal that produced them. RDA
was used to generate a classifier out of 8 selected proteins that correctly
classified the samples with 94.7 ± 8.1% accuracy with respect to breed.
The three misclassified samples are indicated by arrows. (PC1 = 43.2,
PC2 = 24.1).
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